Our overview indicates that only three drug interventions (BBs, antialdosterones, combined ARB/neprilysin inhibitors) significantly reduce SCD and improve overall survival among individuals with HF and reduced ejection fraction. Here, MME is linked to Schnyder corneal dystrophy.